In order to watch this video, you have to log in or create an account, if you don't have one yet.This video is only available to registered participants of the event.
Back in November 2013 the U.S. congress enacted the Drug Supply Chain Security Act (DSCSA). Part of the regulation is that actors within the U.S. pharmaceutical industry must verify the U.S. state license, which is issued by the U.S. Drug Enforcement Administration (DEA), status (and thus the authenticity) of every trading partner within their supply chain. And this does not stop just by direct trading partners a pharmaceutical supply chain actor might have, the regulation states, that also indirect trading partner’s U.S. state license status must be proofed.
Language: English • Duration: 21:19 • Resolution: 1280x720
KuppingerCole on social media
How can we help you
Send an inquiry
Call Us +49 211 2370770
Mo – Fr 8:00 – 17:00